Dr Venkatraman Radhakrishnan

Dr. Gangothri Selvarajan, MD, DM

Associate Professor, Medical Oncology

Cancer Institute (WIA), Chennai, India

Dr. Gangothri Selvarajan is a highly qualified Medical Oncologist with advanced dual-specialty training in Radiation Oncology and Medical Oncology, currently serving as Associate Professor of Medical Oncology at Cancer Institute (WIA), Chennai, one of India’s premier tertiary cancer care and academic institutions .

________________________________________

Academic Qualifications and Specialist Training

Dr. Selvarajan completed her MBBS from Chengalpattu Medical College, followed by an MD in Radiation Oncology from Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, and subsequently obtained her DM in Medical Oncology from Madras Medical College, Chennai—one of the highest superspecialty qualifications in oncology in India.

She also holds the Specialty Certificate in Medical Oncology (MRCP-SCE) from the Federation of the Royal Colleges of Physicians, United Kingdom, and has successfully cleared the European Society for Medical Oncology (ESMO) Examination, reflecting adherence to international standards of oncology practice.

________________________________________

Clinical Roles and Patient Care

At Cancer Institute (WIA), Dr. Gangothri Selvarajan is actively involved in:

• Comprehensive outpatient and inpatient medical oncology services

• Participation in multidisciplinary tumor boards

• Evidence-based systemic therapy planning for complex solid tumors

• Teaching and mentoring DM Medical Oncology fellows

• Conducting journal clubs, academic discussions, and clinical audits

Her primary clinical interests include breast cancer, gastrointestinal malignancies, gynecologic cancers, thoracic oncology, and precision oncology, with emphasis on individualized treatment strategies and real-world outcome optimization .

________________________________________

Research Experience and Clinical Trial Leadership

Dr. Selvarajan has extensive experience in clinical research and investigator-initiated trials, serving as Principal Investigator or Co-Primary Investigator in several national and multicentric randomized controlled trials.

Key leadership roles include:

• NAGA Trial (Phase III, Multicentric RCT) – Site Principal Investigator

A DHR-funded randomized study comparing neoadjuvant versus adjuvant chemotherapy in resectable gastric adenocarcinoma.

• SOCCER Trial (Phase II) – Co-Primary Investigator

Evaluating organ preservation strategies in rectal cancer.

• Biosimilar Pertuzumab Trial (Phase III) – Site Principal Investigator

Conducted in patients with HER2-positive metastatic breast cancer.

She has also contributed as Co-Investigator in multiple Phase II and Phase III trials in breast cancer, lymphoma, triple-negative breast cancer, metastatic disease, and supportive oncology. Abstracts from these studies have been presented at ASCO, ESMO, ESTRO, ASH, and KINGCA scientific meetings .

________________________________________

Publications and Academic Contributions

Dr. Gangothri Selvarajan has authored and co-authored numerous peer-reviewed publications indexed in PubMed, encompassing:

• Inflammatory and oligometastatic breast cancer

• Lymphomas and germ cell tumors

• Precision oncology and immunotherapy

• Real-world clinical outcome analyses

Her scholarly work contributes significantly to institutional academic output and supports research metrics required for accreditation and ranking .

________________________________________

Awards, Gold Medals, and Recognitions

Her academic excellence has been recognized through multiple honors, including:

• First Prize (Gold Medal) – Pediatric Solid Tumor Quiz, Tata Memorial Hospital

• Multiple International Travel Grant Awards – ESMO (Singapore), ESMO-Asia, International Gastric Cancer Congress (China)

• Third Prize – INDO-UK Oncology Summit Quiz

• ESTRO E-Poster Selection

• ASCO Abstract Publications

• Best Presentation Awards at national oncology conferences

These recognitions reflect sustained excellence in academic oncology, clinical research, and mentorship .

________________________________________

International Fellowships and Advanced Training

Dr. Gangothri Selvarajan has completed advanced international training and fellowships at:

• National University Hospital (NUH), Singapore – Clinical Fellow in Advanced Gastrointestinal Oncology

• Erasmus MC, Rotterdam – Personalized oncology and bioinformatics traineeship

• Max Planck Institute, Germany – Artificial intelligence in healthcare and bioinformatics traineeship

• Princess Margaret Cancer Centre, Canada – Lung cancer preceptorship

She has formal training in next-generation sequencing (NGS), bioinformatics, proteomics, and translational oncology, strengthening institutional precision medicine capabilities.

________________________________________

Professional Memberships and Academic Service

Dr. Selvarajan is an active member of:

• European Society for Medical Oncology (ESMO)

• American Society of Clinical Oncology (ASCO)

• Indian Society of Medical and Paediatric Oncology (ISMPO)

• Association of Radiation Oncologists of India (AROI)

• Tamil Nadu Medical and Pediatric Oncologist Society (TAMPOS)

She also serves as a peer reviewer for national and international oncology journals and regularly contributes to continuing medical education (CME) programs.

________________________________________

Professional Outlook

Dr. Gangothri Selvarajan is committed to delivering ethical, evidence-based, and patient-centered cancer care, while advancing clinical research, academic oncology, and structured oncology training. Her work integrates multidisciplinary care, clinical trials, and precision oncology to enhance patient outcomes and institutional excellence.

________________________________________